1. Home
  2. ALUR

as 04-01-2025 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Nasdaq

Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Founded: 2009 Country:
United States
United States
Employees: N/A City: NATICK
Market Cap: 19.1M IPO Year: N/A
Target Price: $22.83 AVG Volume (30 days): 4.1M
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -11.64 EPS Growth: N/A
52 Week Low/High: $2.15 - $98.75 Next Earning Date: 03-26-2025
Revenue: $32,110,000 Revenue Growth: -39.94%
Revenue Growth (this year): 2.18% Revenue Growth (next year): 35.85%

ALUR Daily Stock ML Predictions

Share on Social Networks: